Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score.
Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score.
复制标题
DOI:
10.1016/s1474-4422(09)70275-3
复制
发表时间:
2009-12
期刊:
影响因子:
48
通讯作者:
Karlson, Elizabeth W.
中科院分区:
文献类型:
--
作者:
De Jager, Philip L.;Chibnik, Lori B.;Cui, Jing;Reischl, Joachim;Lehr, Stephan;Simon, K. Claire;Aubin, Cristin;Bauer, David;Heubach, Juergen F.;Sandbrink, Rupert;Tyblova, Michaela;Lelkova, Petra;Havrdova, Eva;Pohl, Christoph;Horakova, Dana;Ascherio, Alberto;Hafler, David A.;Karlson, Elizabeth W.
Predicting susceptibility to multiple sclerosis may have important clinical applications either as part of a diagnostic algorithm or as a tool with which to identify high-risk individuals for prospective studies. Here, we examine the utility of an aggregate measure of risk of multiple sclerosis (MS) based on genetic susceptibility loci. Secondarily, we assess the added effect of environmental risk factors that have been associated with susceptibility for MS. We created a weighted genetic risk score (wGRS) that includes 16 MS susceptibility loci. We tested our model using data from (1) 2215 MS cases and 2189 controls (derivation samples), (2) a validation set of 1340 cases and 1109 controls taken from several MS therapeutic trials (TT samples), and (3) a second validation set of 143 cases and 281 controls from the U.S. Nurses’ Health Studies I and II (NHS) for whom we also have information regarding exposure to smoking and Epstein-Barr Virus (EBV). . Patients with wGRS > 1.25 standard deviations from the mean had a significantly higher odds ratio for MS in all datasets. The area under the curve for a purely genetic model was 0.70 and for a gender + genetic model was 0.74 in the derivation samples (P <0.0001), 0.64 and 0.72 in the TT cohort (P <0.0001). Similarly, consideration of smoking and immune response to EBV enhanced the AUC of 0.64 for the genetic model to 0.68 in the NHS cohort (P =0.02). The wGRS does not appear to be correlated with conversion of a clinically isolated syndrome to MS. The current combination of 16 susceptibility alleles into a wGRS modestly predicts MS risk and shows consistent discriminatory ability in independent subject samples and is enhanced by considering non-genetic risk factors.